[go: up one dir, main page]

DE69628203D1 - Verfahren zur herstellung von phenylimidazolin-derivaten - Google Patents

Verfahren zur herstellung von phenylimidazolin-derivaten

Info

Publication number
DE69628203D1
DE69628203D1 DE69628203T DE69628203T DE69628203D1 DE 69628203 D1 DE69628203 D1 DE 69628203D1 DE 69628203 T DE69628203 T DE 69628203T DE 69628203 T DE69628203 T DE 69628203T DE 69628203 D1 DE69628203 D1 DE 69628203D1
Authority
DE
Germany
Prior art keywords
phenylimidazoline
derivatives
producing
producing phenylimidazoline
phenylimidazoline derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69628203T
Other languages
English (en)
Other versions
DE69628203T2 (de
Inventor
Rapha L Bouchet
Michel Delthil
Daniel Guilmard
Philippe Mackiewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69628203D1 publication Critical patent/DE69628203D1/de
Publication of DE69628203T2 publication Critical patent/DE69628203T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69628203T 1995-11-16 1996-11-14 Verfahren zur herstellung von phenylimidazolin-derivaten Expired - Fee Related DE69628203T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9513589A FR2741346B1 (fr) 1995-11-16 1995-11-16 Nouveau procede de preparation de derives phenylimidazolidine
FR9513589 1995-11-16
PCT/FR1996/001794 WO1997018197A1 (fr) 1995-11-16 1996-11-14 Nouveau procede de preparation de derives phenylimidazolidine

Publications (2)

Publication Number Publication Date
DE69628203D1 true DE69628203D1 (de) 2003-06-18
DE69628203T2 DE69628203T2 (de) 2004-02-05

Family

ID=9484624

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69628203T Expired - Fee Related DE69628203T2 (de) 1995-11-16 1996-11-14 Verfahren zur herstellung von phenylimidazolin-derivaten

Country Status (29)

Country Link
US (1) US6107488A (de)
EP (1) EP0877738B1 (de)
JP (1) JP2000500150A (de)
KR (1) KR100466991B1 (de)
CN (1) CN1131219C (de)
AR (1) AR004965A1 (de)
AT (1) ATE240300T1 (de)
AU (1) AU718832B2 (de)
BR (1) BR9611573A (de)
CA (1) CA2235335A1 (de)
CU (1) CU22890A3 (de)
CZ (1) CZ144498A3 (de)
DE (1) DE69628203T2 (de)
DK (1) DK0877738T3 (de)
EA (1) EA002658B1 (de)
ES (1) ES2193271T3 (de)
FR (1) FR2741346B1 (de)
HU (1) HUP9904034A3 (de)
IL (1) IL124382A0 (de)
MX (1) MX9803730A (de)
NO (1) NO316514B1 (de)
PL (1) PL189697B1 (de)
PT (1) PT877738E (de)
SI (1) SI0877738T1 (de)
TR (1) TR199800865T2 (de)
TW (1) TW404942B (de)
UA (1) UA67720C2 (de)
WO (1) WO1997018197A1 (de)
ZA (1) ZA969442B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2550447A1 (en) * 2003-12-19 2005-07-07 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies
US7718684B2 (en) * 2004-02-24 2010-05-18 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7709517B2 (en) * 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
LT3412290T (lt) 2006-03-27 2021-04-26 The Regents Of The University Of California Androgeno receptorių moduliatorius, skirtas prostatos vėžio bei su androgeno receptoriais susijusių ligų gydymui
SG170809A1 (en) * 2006-03-29 2011-05-30 Univ California Diarylthiohydantoin compounds
EP2220050A2 (de) 2007-10-26 2010-08-25 The Regents Of The University Of California Diarylhydantoinverbindungen als androgenrezeptormodulatoren
CN102481294A (zh) 2009-09-11 2012-05-30 拜耳医药股份有限公司 作为抗癌药物的取代(杂芳基甲基)乙内酰硫脲
CN102510869B (zh) 2009-09-15 2014-12-24 米兰集团 用于负性工作辐射敏感性平版印刷板的辐射敏感性涂料组合物的共聚物、包含所述共聚物的聚合颗粒和共聚粘合剂
EP2536708A4 (de) 2010-02-16 2013-05-29 Aragon Pharmaceuticals Inc Androgenrezeptormodulatoren und ihre verwendung
ES2570379T3 (es) 2010-09-14 2016-05-18 Mylan Group Copolímeros para composiciones de revestimiento sensibles a radiación en el infrarrojo cercano para planchas de impresión litográfica térmicas positivas
MY180834A (en) 2012-09-26 2020-12-10 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
BR112020007439A2 (pt) 2017-10-16 2020-10-27 Aragon Pharmaceuticals, Inc. antiandrogênios para o tratamento de câncer de próstata resistente à castração não metastática
CN108218784A (zh) * 2018-01-16 2018-06-29 吴江信凯医药科技有限公司 一种尼鲁米特的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4916937B1 (de) * 1970-01-21 1974-04-25
JPS5136332B1 (de) * 1970-12-09 1976-10-07
CH544491A (de) * 1971-03-16 1973-11-30 Ciba Geigy Ag Herbizides Mittel
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine
JPS57197268A (en) * 1981-05-29 1982-12-03 Sumitomo Chem Co Ltd Substituted phenylhydantoin derivative, its preparation, and herbicide containing the same as active ingredient
JPS62298562A (ja) * 1986-06-17 1987-12-25 Nippon Kayaku Co Ltd ブロモアニリン類の製造法
FR2656302B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveau procede de preparation de l'anandron et derives de l'anandron.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2694290B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
EP0877738B1 (de) 2003-05-14
UA67720C2 (en) 2004-07-15
WO1997018197A1 (fr) 1997-05-22
EA199800378A1 (ru) 1998-10-29
AR004965A1 (es) 1999-04-07
JP2000500150A (ja) 2000-01-11
DE69628203T2 (de) 2004-02-05
TR199800865T2 (xx) 1998-08-21
TW404942B (en) 2000-09-11
EP0877738A1 (de) 1998-11-18
SI0877738T1 (en) 2003-10-31
HUP9904034A2 (hu) 2000-05-28
EA002658B1 (ru) 2002-08-29
CZ144498A3 (cs) 1998-09-16
CN1207732A (zh) 1999-02-10
US6107488A (en) 2000-08-22
CU22890A3 (es) 2004-01-23
NO316514B1 (no) 2004-02-02
FR2741346B1 (fr) 1997-12-19
KR19990067639A (ko) 1999-08-25
ES2193271T3 (es) 2003-11-01
NO982237D0 (no) 1998-05-15
ZA969442B (en) 1997-11-11
ATE240300T1 (de) 2003-05-15
PL326491A1 (en) 1998-09-28
PL189697B1 (pl) 2005-09-30
AU7577396A (en) 1997-06-05
IL124382A0 (en) 1998-12-06
NO982237L (no) 1998-07-10
BR9611573A (pt) 1999-05-11
FR2741346A1 (fr) 1997-05-23
HUP9904034A3 (en) 2001-08-28
PT877738E (pt) 2003-09-30
MX9803730A (es) 1998-11-30
KR100466991B1 (ko) 2005-04-06
CA2235335A1 (fr) 1997-05-22
CN1131219C (zh) 2003-12-17
DK0877738T3 (da) 2003-09-08
AU718832B2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
ATE243211T1 (de) Verfahren zur herstellung von dihalogenazolopyrimidinen
DE69525373D1 (de) Verfahren zur herstellung von alumosilikatderivaten
DE59603155D1 (de) Verfahren zur herstellung von hydrotalciten
DE59604922D1 (de) Verfahren zur herstellung von polyalkoholen
DE69602331D1 (de) Verfahren zur herstellung von polyolefin
DE69604277D1 (de) Verfahren zur herstellung von nootkaton
DE69814862D1 (de) Verfahren zur herstellung von pyridinderivaten
DE69519379D1 (de) Verfahren zur herstellung von trifluorethylene
ATE187727T1 (de) Verfahren zur herstellung von imidazo- benzodiazepin-derivaten
ATE229021T1 (de) Verfahren zur herstellung von imidazochinazolinon-derivaten
DE59601604D1 (de) Verfahren zur herstellung von n-aryl- und n-hetarylhydroxylaminen
ATE240300T1 (de) Verfahren zur herstellung von phenylimidazolin- derivaten
ATE267812T1 (de) Verfahren zur herstellung von n-substituierten 3- hydroxypyrazolen
ATE303134T1 (de) Verfahren zur herstellung von flavano-lignan- zubereitungen
ATE309230T1 (de) Verfahren zur herstellung von 2- chlorthiazolderivaten
ATE238302T1 (de) Verfahren zur herstellung von thiazolidindion- derivaten
DE59601895D1 (de) Verfahren zur herstellung von butyrolactonen
ATE203046T1 (de) Verfahren zur herstellung von pigmenten
ATE181554T1 (de) Verfahren zur herstellung von n- phosphonomethylglyzin
DE69616322D1 (de) Verfahren zur herstellung von 3-isochromanonen
DE69808068D1 (de) Verfahren zur herstellung von indolderivaten
ATE207900T1 (de) Verfahren zur herstellung von ropivacainehydrochlorid-monohydrat
DE69601993D1 (de) Verfahren zur herstellung von doxorubicin
ATE219056T1 (de) Verfahren zur herstellung von alpha- bromolactamderivaten
DE69615836D1 (de) Verfahren zur herstellung von boroxyd

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8339 Ceased/non-payment of the annual fee